Innovation in healthcare is often controversial and raises ethical debates concerning the impact of its diffusion on the moral values of the society. In particular in the field of reproductive and genetic technologies, the consideration of (bio)ethical issues might influence acceptance and reimbursement in the public healthcare system.
Within this framework, the aim of this research project is to investigate to what extent the assessment of ethical aspects plays a role in the decision making process concerning the uptake of medical innovations in the healthcare system and whether this happens in a manner that is consistent with the fundamental normative framework of the rule of law. For this purpose it is necessary to reflect upon the principle of ethical neutrality of the state and the extent to which the state can integrate a certain ethical view in its decisions and regulatory choices.
The goal of the study is pursued by selecting artificial reproductive technologies as a case study, with a specific focus on two techniques developed in the field of diagnostics (preimplantation genetic diagnosis and non-invasive prenatal testing).